Results 1 to 10 of about 10,975,472 (295)

Effects of β‑hydroxybutyrate on restoring autophagic flux and mitochondrial function in macrophages exposed to oxidized low‑density lipoprotein. [PDF]

Mol Med Rep
Luo W, He M, Wang H.
europepmc   +1 more source

Causal Effect of Low-Density Lipoprotein Cholesterol on Chronic Kidney Disease: A Mendelian Randomization Study. [PDF]

Biochem Res Int
Zhou D, Zheng K, Zhang S, Zheng B.
europepmc   +1 more source

Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goals. [PDF]

Eur Heart J
Kataoka Y, Ray KK, Nicholls SJ, Katasako-Yabumoto A, Kitahara S, Hosoda H, Mitsui K, Murai K, Sawada K, Matama H, Iwai T, Honda S, Fujino M, Yoneda S, Nakao K, Takagi K, Asaumi Y, Noguchi T.   +17 more
europepmc   +1 more source

Correction to: Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction. [PDF]

J Am Heart Assoc
europepmc   +1 more source

Low-density lipoprotein cholesterol and risk of COPD: a Mendelian randomization study. [PDF]

Sci Rep
Justesen JF, Wadström BN, Marott SCW, Landt EM, Nordestgaard BG, Afzal S, Dahl M.   +6 more
europepmc   +1 more source

Real-World Low-Density Lipoprotein Cholesterol Control After Transitioning From Evolocumab to Inclisiran. [PDF]

Circ Rep
Tabata T, Chinen T, Nakamura K.
europepmc   +1 more source

Drug-Intervention Lag Phase Between Low-Density Lipoprotein-Cholesterol Lowering and Coronary Plaque Stabilization. [PDF]

Circ Rep
Takahashi N, Iwata H.
europepmc   +1 more source

Lipoprotein X: A Cause for Misleading Levels of Low-Density Lipoprotein. [PDF]

JACC Case Rep
Lee R, Baum S, Roman T, Joshi-Guske P, Aggarwal M.   +4 more
europepmc   +1 more source